Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.50
+0.85 (4.82%)
Jul 16, 2025, 1:51 PM CST
-54.60%
Market Cap1.03B
Revenue (ttm)895.32M
Net Income (ttm)-57.21M
Shares Out55.87M
EPS (ttm)-1.03
PE Ration/a
Forward PEn/a
Dividend0.40 (2.26%)
Ex-Dividend Daten/a
Volume205,726
Average Volume49,125
Open17.65
Previous Close17.65
Day's Range17.65 - 19.20
52-Week Range15.75 - 41.00
Beta0.15
RSI63.51
Earnings DateAug 12, 2025

About Anxo Pharmaceutical

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroentero... [Read more]

Sector Healthcare
Founded 2003
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6677
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.